Endoscopic treatment of benign tracheal stenosis: a single-centre study
Swiss Medical Weekly · 17.06.2024 · 154 (6) · 3363
DOI: 10.57187/s.3363 ↗Kurz gefasst
Fachartikel in der Zeitschrift Swiss Medical Weekly, online erschienen am 17.06.2024. Verfasst von Deniz Kather und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland. Hauptthemen laut MEDLINE: Tracheal Stenosis. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
BACKGROUND: Benign tracheal stenosis is relatively rare but remains a significant chronic disease due to its drastic symptoms including dyspnoea and inspiratory stridor, and consequent negative effect on quality of life. Traditionally, the surgical approach by resection of the stenotic tracheal segment has been the therapy of choice. However, endoscopic techniques have arisen and may offer a safe and less invasive alternative. OBJECTIVES: The aim of the retrospective study was to evaluate procedure-related safety and outcome of endoscopic treatment of benign tracheal stenosis at a single centre. METHODS: The study included all patients at our institution who between 2013 and 2022 had received endoscopic treatment of benign tracheal stenosis by rigid tracheoscopy, radial incision by electric papillotomy needle and dilation (endoscopic tracheoplasty) followed by triamcinolone acetonide as a local submucosal injection and additionally, from 2020, budesonide inhalation. RESULTS:A total of 22 patients were treated in a total of 38 interventions, each resulting in immediate improvement of symptoms. There were no peri-interventional complications or mortality. Of the 38 interventions, 11 received no triamcinolone acetonide administration, resulting in a 54.5% recurrence rate after an average of 21.1 (±18.0) months, while 27 had local triamcinolone acetonide, with a 37% recurrence rate. Since 2020, we additionally initiated post-interventional budesonide inhalation as recurrence prophylaxis for newly admitted patients and patients with recurrences(n = 8), of whom only one (12.5%) has to date experienced a recurrence. CONCLUSION: Our results indicate that endoscopic tracheoplasty offers a safe and successful, minimally invasive alternative to open surgery for patients with benign tracheal stenosis. We recommend local administration of triamcinolone into the mucosa as an additional treatment to decrease the risk of recurrence. However, given the uncontrolled study design and low sample size, safety and effectiveness cannot be conclusively demonstrated. Nonetheless, our findings suggest promising avenues for further investigation. Further studies on the additional benefit of inhaled corticosteroids are warranted.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pulmonology, University Hospital Zurich, Zurich, Switzerland.
- Department of Internal Medicine, Uster Hospital, Uster, Switzerland.
Zitieren
APA
Kather, D., Steinack, C., & Franzen, D. P. (2024). Endoscopic treatment of benign tracheal stenosis: a single-centre study. Swiss Medical Weekly, 154(6), 3363. https://doi.org/10.57187/s.3363
Vancouver
Kather D, Steinack C, Franzen DP. Endoscopic treatment of benign tracheal stenosis: a single-centre study. Swiss Medical Weekly. 2024;154(6):3363. doi:10.57187/s.3363
BibTeX
@article{Kather2024,
author = {Kather, Deniz and Steinack, Carolin and Franzen, Daniel P},
title = {Endoscopic treatment of benign tracheal stenosis: a single-centre study},
journal = {Swiss Medical Weekly},
year = {2024},
volume = {154},
number = {6},
pages = {3363},
doi = {10.57187/s.3363}
}
EUVIMED